histone deacetylase inhibitors

You have access
Histone Deacetylase Inhibitors and Anaplastic Thyroid Carcinoma
ELEFTHERIOS SPARTALIS, DIMITRIOS I. ATHANASIADIS, DIMOSTHENIS CHRYSIKOS, MICHAEL SPARTALIS, GEORGIOS BOUTZIOS, DIMITRIOS SCHIZAS, NIKOLAOS GARMPIS, CHRISTOS DAMASKOS, STAVROULA A. PASCHOU, ARGYRIOS IOANNIDIS, GERASIMOS TSOUROUFLIS, DIMITRIOS DIMITROULIS and NIKOLAOS I. NIKITEAS

Anticancer Research March 2019, 39 (3) 1119-1127; DOI: https://doi.org/10.21873/anticanres.13220
You have access
Additive Interaction of Cisplatin and Histone Deacetylase Inhibitors Combined Treatment in Rhabdomyosarcoma Cells – An Isobolographic Analysis
AGATA JARZĄB, JAROGNIEW J. ŁUSZCZKI, MAŁGORZATA GUZ, EWELINA GUMBAREWICZ, KRZYSZTOF POLBERG and ANDRZEJ STEPULAK

Anticancer Research March 2017, 37 (3) 1067-1074;
You have access
The Effects of Histone Deacetylase Inhibitor and Calpain Inhibitor Combination Therapies on Ovarian Cancer Cells
KAROLINA LAPINSKA, GENEVIEVE HOUSMAN, SHANNON BYLER, SARAH HEERBOTH, AMBER WILLBANKS, ANUJA OZA and SIBAJI SARKAR

Anticancer Research November 2016, 36 (11) 5731-5742;
You have access
Valproic Acid Alters Angiogenic and Trophic Gene Expression in Human Prostate Cancer Models
RAJU CHELLURI, TIFFANY CAZA, MARK R. WOODFORD, JAY E. REEDER, GENNADY BRATSLAVSKY and TIMOTHY BYLER

Anticancer Research October 2016, 36 (10) 5079-5086;
You have access
Genetic and Epigenetic Aspects of Breast Cancer Progression and Therapy
SHANNON BYLER, SARAH GOLDGAR, SARAH HEERBOTH, MEGHAN LEARY, GENEVIEVE HOUSMAN, KIMBERLY MOULTON and SIBAJI SARKAR

Anticancer Research March 2014, 34 (3) 1071-1077;

Main menu

User menu

Search

histone deacetylase inhibitors